• NRNP 6630 Final Exam
Question 1 I
0 out of 0 points
I I I I
When completing this exam, did you comply with Walden University’s Code of
I I I I I I I I I I I
Conduct including the expectations for academic integrity?
I I I I I I I
Selected Answer: Yes I
• Question 2 I
1 out of 1 points
I I I I
The PMHNP understands that slow-dose extended release stimulants are most
I I I I I I I I I
appropriate for which patient with ADHD?
I I I I I I
Selected Answer: c. I I
8-year-old patient I
• Question 3 I
1 out of 1 points
I I I I
Jordan is diagnosed with obsessive compulsive disorder. He has been trialed
I I I I I I I I I I
Ion several different SSRIs and is currently on high dose sertraline. He reports
I I I I I I I I I I I I
an inability to carry out responsibilities because of an obsession with handwashing.
I I I I I I I I I I I I
Which is the best treatment option for Jordan?
I I I I I I I I
Selected Answer: a. I I
Maintain the same dose of sertraline and add quetiapine
I I I I I I I I
• Question 4 I
1 out of 1 points
I I I I
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
I I I I I I I I I I I
aggressive behaviors in patients with the student. Why does the PMHNP
I I I I I I I I I I I
prescribe a standard dose of atypical antipsychotics?
I I I I I I I
Selected c. I
Answer:
I The doses are based on achieving 60% D2 receptor I I I I I I I I
occupancy.
I
• Question 5 I
1 out of 1 points
I I I I
,A 72-year-old male patient is in the early stages of Alzheimer’s disease. The
I I I I I I I I I I I I
PMHNP determines that improving memory is a key consideration in selecting
I I I I I I I I I I I
a medication. Which of the following would be an appropriate choice?
I I I I I I I I I I I I
Selected Answer: c. I I
All of these are correct
I I I I
• Question 6 I
1 out of 1 points
I I I I
A 71-year-old male patient comes to an appointment with his 65-year-old wife.
I I I I I I I I I I I
They are both having concerns related to her memory and ability to recognize
I I I I I I I I I I I I I
faces. The PMNHP is considering prescribing memantine (Namenda) based on the
I I I I I I I I I I I
following symptoms:
I I
Selected Answer: c. I I
Amnesia, apraxia, agnosia I I
• Question 7 I
1 out of 1 points
I I I I
The PMHNP is working with the student to care for a patient with diabetic
I I I I I I I I I I I I I
peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not
I I I I I I I I I I I I
consistently useful in treating this particular patient’s pain. What is the best
I I I I I I I I I I I I
response by the PMHNP?
I I I I
Selected Answer: b. I I
“SSRIs only increase serotonin levels.”
I I I I
• Question 8 I
1 out of 1 points
I I I I
The PMHNP is caring for a patient who openly admitted to drinking a quart of vodka
I I I I I I I I I I I I I I I
daily. Prior to prescribing this patient disulfiram (Antabuse), it is important for the
I I I I I I I I I I I I I
PMHNP to:
I I
Selected Answer: b. I I
Evaluate the patient’s willingness to abstain from alcohol
I I I I I I I
• Question 9 I
0 out of 1 points
I I I I
The PMHNP is meeting with the parents of an 8-year-old patient who is
I I I I I I I I I I I I
receiving an initial prescription for D-amphetamine. The PMHNP
I I I I I I I I
, demonstrates appropriate prescribing practices when she prescribes the following
I I I I I I I I I
dose:
I II
Selected Answer: a. I I
The child will take 10–40 mg, daily.
I I I I I I
• Question 10 I
1 out of 1 points
I I I I
The PMHNP is assessing a patient who will be receiving phentermine +
I I I I I I I I I I I
topiramate combination (QSYMIA). QSYMIA would be contraindicated in which
I I I II I I I I I
patient?
I
Selected Answer: d. I I
A 37-year-old female that is being treated with phenelzine
I I I I I I I I
• Question 11 I
0 out of 1 points
I I I I
Jacob is a 7-year-old pediatric patient who has significant oppositional
I I I I I I I I I
symptoms associated with his ADHD diagnosis. What is the best treatment for this
I I I I I I I I I I I I I
patient?
I
Selected Answer: b. I I
Prescribe a methylphenidate alone. I I I
• Question 12 I
1 out of 1 points
I I I I
The PMHNP is attempting to treat a patient’s chronic pain by having the agent
I I I I I I I I I I I I I
bind the open channel conformation of VSCCs to block those channels with a
I I I I I I I I I I I I I
“use-dependent” form of inhibition. Which agent will the PMHNP most likely select?
I I I I I I I I I I I I
Selected Answer: c. I I
Pregabalin (Lyrica) I
• Question 13 I
1 out of 1 points
I I I I
An adult patient presents with a history of alcohol addiction and attention
I I I I I I I I I I I
deficit hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP
I I I I I I I I I
determines which of the following medications may be the best treatment option?
I I I I I I I I I I I I I
Selected Answer: c. I I
Question 1 I
0 out of 0 points
I I I I
When completing this exam, did you comply with Walden University’s Code of
I I I I I I I I I I I
Conduct including the expectations for academic integrity?
I I I I I I I
Selected Answer: Yes I
• Question 2 I
1 out of 1 points
I I I I
The PMHNP understands that slow-dose extended release stimulants are most
I I I I I I I I I
appropriate for which patient with ADHD?
I I I I I I
Selected Answer: c. I I
8-year-old patient I
• Question 3 I
1 out of 1 points
I I I I
Jordan is diagnosed with obsessive compulsive disorder. He has been trialed
I I I I I I I I I I
Ion several different SSRIs and is currently on high dose sertraline. He reports
I I I I I I I I I I I I
an inability to carry out responsibilities because of an obsession with handwashing.
I I I I I I I I I I I I
Which is the best treatment option for Jordan?
I I I I I I I I
Selected Answer: a. I I
Maintain the same dose of sertraline and add quetiapine
I I I I I I I I
• Question 4 I
1 out of 1 points
I I I I
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
I I I I I I I I I I I
aggressive behaviors in patients with the student. Why does the PMHNP
I I I I I I I I I I I
prescribe a standard dose of atypical antipsychotics?
I I I I I I I
Selected c. I
Answer:
I The doses are based on achieving 60% D2 receptor I I I I I I I I
occupancy.
I
• Question 5 I
1 out of 1 points
I I I I
,A 72-year-old male patient is in the early stages of Alzheimer’s disease. The
I I I I I I I I I I I I
PMHNP determines that improving memory is a key consideration in selecting
I I I I I I I I I I I
a medication. Which of the following would be an appropriate choice?
I I I I I I I I I I I I
Selected Answer: c. I I
All of these are correct
I I I I
• Question 6 I
1 out of 1 points
I I I I
A 71-year-old male patient comes to an appointment with his 65-year-old wife.
I I I I I I I I I I I
They are both having concerns related to her memory and ability to recognize
I I I I I I I I I I I I I
faces. The PMNHP is considering prescribing memantine (Namenda) based on the
I I I I I I I I I I I
following symptoms:
I I
Selected Answer: c. I I
Amnesia, apraxia, agnosia I I
• Question 7 I
1 out of 1 points
I I I I
The PMHNP is working with the student to care for a patient with diabetic
I I I I I I I I I I I I I
peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not
I I I I I I I I I I I I
consistently useful in treating this particular patient’s pain. What is the best
I I I I I I I I I I I I
response by the PMHNP?
I I I I
Selected Answer: b. I I
“SSRIs only increase serotonin levels.”
I I I I
• Question 8 I
1 out of 1 points
I I I I
The PMHNP is caring for a patient who openly admitted to drinking a quart of vodka
I I I I I I I I I I I I I I I
daily. Prior to prescribing this patient disulfiram (Antabuse), it is important for the
I I I I I I I I I I I I I
PMHNP to:
I I
Selected Answer: b. I I
Evaluate the patient’s willingness to abstain from alcohol
I I I I I I I
• Question 9 I
0 out of 1 points
I I I I
The PMHNP is meeting with the parents of an 8-year-old patient who is
I I I I I I I I I I I I
receiving an initial prescription for D-amphetamine. The PMHNP
I I I I I I I I
, demonstrates appropriate prescribing practices when she prescribes the following
I I I I I I I I I
dose:
I II
Selected Answer: a. I I
The child will take 10–40 mg, daily.
I I I I I I
• Question 10 I
1 out of 1 points
I I I I
The PMHNP is assessing a patient who will be receiving phentermine +
I I I I I I I I I I I
topiramate combination (QSYMIA). QSYMIA would be contraindicated in which
I I I II I I I I I
patient?
I
Selected Answer: d. I I
A 37-year-old female that is being treated with phenelzine
I I I I I I I I
• Question 11 I
0 out of 1 points
I I I I
Jacob is a 7-year-old pediatric patient who has significant oppositional
I I I I I I I I I
symptoms associated with his ADHD diagnosis. What is the best treatment for this
I I I I I I I I I I I I I
patient?
I
Selected Answer: b. I I
Prescribe a methylphenidate alone. I I I
• Question 12 I
1 out of 1 points
I I I I
The PMHNP is attempting to treat a patient’s chronic pain by having the agent
I I I I I I I I I I I I I
bind the open channel conformation of VSCCs to block those channels with a
I I I I I I I I I I I I I
“use-dependent” form of inhibition. Which agent will the PMHNP most likely select?
I I I I I I I I I I I I
Selected Answer: c. I I
Pregabalin (Lyrica) I
• Question 13 I
1 out of 1 points
I I I I
An adult patient presents with a history of alcohol addiction and attention
I I I I I I I I I I I
deficit hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP
I I I I I I I I I
determines which of the following medications may be the best treatment option?
I I I I I I I I I I I I I
Selected Answer: c. I I
